World Health Organization (WHO) and its relevant partners have revealed their plans to purchase 2 billion doses of vaccines for the most vulnerable people in the world.
The COVID-19 doses would be delivered to nations and there will be a need to prioritize vaccinating the high-risks persons who are above the age of 65 and other adults who suffer from critical conditions.
The key partners in this project include Gavi, the Vaccine Alliance, and Coalition for Epidemic Preparedness Innovations (CEPI).
To execute the plan, WHO and its partners will be needing $18.1 billion (₦7 trillion). This is part of the organization’s mission to ensure that all countries have access to therapeutics, diagnostics, and COVID-19 vaccines.
Countries that can afford to get the vaccines directly do this by using the direct purchase agreement with various drug manufacturers around the world. They will also be willing to pay ahead for the cost of making the vaccine; making them the first in line to get the vaccine.
“It’s risky for them to do that and it’s also not ethically the right approach; because it leaves the rest of the world without vaccine doses,” said Soumya Swaminathan, WHO’s chief scientist.
According to Gavi GEO, Seth Berkley, about 7% of vaccines make it through preclinical development; and maybe 15% to 20% that enter the clinic is successful.